APGE
Apogee Therapeutics

378
Mkt Cap
$4.36B
Volume
298,299.00
52W High
$67.57
52W Low
$26.20
PE Ratio
-14.78
APGE Fundamentals
Price
$64.01
Prev Close
$63.83
Open
$64.49
50D MA
$49.68
Beta
0.00
Avg. Volume
895,565.30
EPS (Annual)
-$3.30
P/B
7.93
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Apogee Therapeutics (NASDAQ:APGE) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Apogee Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
Michael Thomas Henderson Sells 20,000 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the stock in a transaction dated Thursday, November 13th. The stock was sold at an average...
MarketBeat·6d ago
News Placeholder
Apogee Therapeutics Inc. (NASDAQ:APGE) Given Consensus Rating of "Moderate Buy" by Brokerages
Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) has received an average rating of "Moderate Buy" from the twelve research firms that are covering the firm, Marketbeat.com reports. One...
MarketBeat·6d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High - What's Next?
Apogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Still a Buy...
MarketBeat·7d ago
News Placeholder
Wedbush Equities Analysts Lift Earnings Estimates for APGE
Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) - Investment analysts at Wedbush boosted their FY2025 earnings per share (EPS) estimates for Apogee Therapeutics in a note issued to investors on...
MarketBeat·7d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Shares Up 7.3% - Time to Buy?
Apogee Therapeutics (NASDAQ:APGE) Shares Up 7.3% - Time to Buy...
MarketBeat·8d ago
News Placeholder
Fox Run Management L.L.C. Makes New Investment in Apogee Therapeutics Inc. $APGE
Fox Run Management L.L.C. bought a new position in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·8d ago
News Placeholder
Apogee Therapeutics (NASDAQ:APGE) Posts Earnings Results, Beats Estimates By $0.03 EPS
Apogee Therapeutics (NASDAQ:APGE - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($1.11) EPS for the quarter, beating the consensus estimate of ($1.14) by $0.03...
MarketBeat·9d ago
News Placeholder
Is Apogee Therapeutics Inc. (APGE) Outperforming Other Medical Stocks This Year?
Here is how Apogee Therapeutics Inc. (APGE) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
Zacks·9d ago

Latest APGE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.